Borderline Resectable Pancreatic Adenocarcinoma: Tumor Volume and CA19-9 Reduction Following Neoadjuvant Chemotherapy and Fractionated Stereotactic Body Radiation Therapy Correlates With Pathologic Response

✍ Scribed by Lin, C.; Lazenby, A.J.; Hussain, S.M.; Sasson, A.R.; Chen, S.; Ly, Q.P.; Schwarz, J.K.; Kos, M.E.; Are, C.; Grem, J.L.

• Book ID: 122674811
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 76 KB
• Volume: 84
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2012.07.840